Cases & Deals

Empryrean Bioscience obtains dismissal of securities litigation

Clients Empyrean Bioscience

Jones Day represented Empyrean Bioscience, Inc., a marketer of personal care disease-prevention products, and certain officers and directors in an action alleging securities disclosure violations in connection with the status of an application for FDA product approval. The ruling granted dismissal of plaintiffs' Securities Act claim with prejudice and dismissal of the Securities Exchange Act claim with leave to amend.

In re Empyrean Bioscience, Inc. Securities Litigation, No. 1:02-CV-1439 (N.D. Ohio)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.